SCHEMBL12489263

SCHEMBL12489263

COC(=O)C/C=C/c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.51
▸ CYP4F2 P78329 2/20 0.50
▸ CYP4A11 Q02928 2/20 0.50
▸ KDM4E B2RXH2 7/20 0.48
▸ ALDH1A1 P00352 6/20 0.48
▸ GAA P10253 1/20 0.48
▸ KMT2A Q03164 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ HCRTR1 O43613 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MTNR1A P48039 1/20 0.46
▸ MTNR1B P49286 1/20 0.46
▸ HPGD P15428 4/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ GABRP O00591 1/20 0.45
▸ GABRD O14764 1/20 0.45
▸ PDE5A O76074 1/20 0.45
▸ LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1071505 0.80 KIF11 (0.55) KIF11KDM4EALDH1A1GAAKMT2A
SCHEMBL30440640 0.80 KIF11 (0.55) KIF11KDM4EALDH1A1GAAKMT2A
SCHEMBL12408499 0.80 KIF11 (0.55) KIF11KDM4EALDH1A1GAAKMT2A
SCHEMBL8125643 0.78 KIF11 (0.58) KIF11KDM4EALDH1A1GAAKMT2A
Carbazole SCHEMBL11584093 0.75 KIF11 (0.58) KIF11KDM4EALDH1A1GAAKMT2A
SCHEMBL13908714 0.74 CYP4F2 (0.65) CYP4F2CYP4A11ALDH1A1MAPTRAB9A
SCHEMBL13697649 0.74 KDM4E (0.55) KIF11KDM4EALDH1A1GAAKMT2A
SCHEMBL2877458 0.74 CYP4F2 (0.64) CYP4F2CYP4A11ALDH1A1KMT2AMEN1
SCHEMBL2877454 0.74 CYP4F2 (0.64) CYP4F2CYP4A11ALDH1A1KMT2AMEN1
SCHEMBL22804962 0.74 KIF11 (0.61) KIF11KDM4EALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7972792-B2 Sequence-specific nucleic acid purification method manner JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2011-07-05 — — US disclosed
US-20110034683-A1 SEQUENCE-SPECIFIC NUCLEIC ACID PURIFICATION METHOD MANNER JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2011-02-10 — — US disclosed
US-20100274000-A1 LIGHT-RESPONSIVE ARTIFICIAL NUCLEOTIDE HAVING PHOTO-CROSSLINKING ABILITY JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2010-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100274000-A1 LIGHT-RESPONSIVE ARTIFICIAL NUCLEOTIDE HAVING PHOTO-CROSSLINKING ABILITY NME2, NR2E3, NSUN2 KIF11 2780/4885CYP4F2 1330/4885CYP4A11 2420/4885
US-20110034683-A1 SEQUENCE-SPECIFIC NUCLEIC ACID PURIFICATION METHOD MANNER UNG, LIG1, NUDT21 KIF11 2663/4885CYP4F2 2465/4885CYP4A11 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback